Phase 3Status unknown

A Novel Transcatheter Tricuspid Annuloplasty Technology for the Treatment of Moderate-to-Severe or Greater Tricuspid Regurgitation

Sponsor
West China Hospital of Sichuan University
Enrolment
20 planned
Conditions
Moderate-to-severe or greater tricuspid regurgitation
Interventions
Transcatheter tricuspid annuloplasty
Ages
adults, older adults
Registry
ChiCTR2600130365

Full record on the Chinese Clinical Trial RegistrySource: WHO ICTRP, processed 24 August 2026

Primary outcomes

  • The incidence of tricuspid regurgitation reduction of at least one grade at 1 month after operation;

History

  1. Started

  2. Last registry update

  3. Registered